| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chlamydiales | 13 | 2018 | 21 | 6.42 | Why? |
| Microbiology | 5 | 2018 | 134 | 2.47 | Why? |
| Chlamydia Infections | 12 | 2018 | 248 | 2.08 | Why? |
| Bacteria | 8 | 2019 | 1897 | 1.58 | Why? |
| Genome, Bacterial | 12 | 2019 | 446 | 1.51 | Why? |
| Bartonella | 2 | 2018 | 24 | 1.49 | Why? |
| Acanthamoeba castellanii | 4 | 2017 | 39 | 1.42 | Why? |
| Rickettsia | 2 | 2018 | 101 | 1.42 | Why? |
| Giant Viruses | 2 | 2017 | 27 | 1.37 | Why? |
| Chlamydia | 5 | 2018 | 47 | 1.31 | Why? |
| Bacterial Toxins | 2 | 2018 | 185 | 1.27 | Why? |
| Chlamydia trachomatis | 8 | 2018 | 172 | 1.26 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2019 | 449 | 1.22 | Why? |
| DNA Viruses | 2 | 2017 | 184 | 1.17 | Why? |
| Automation, Laboratory | 2 | 2017 | 536 | 1.09 | Why? |
| Whole Genome Sequencing | 7 | 2021 | 3239 | 1.03 | Why? |
| Bacterial Proteins | 8 | 2019 | 1318 | 0.89 | Why? |
| Abortion, Veterinary | 2 | 2017 | 10 | 0.89 | Why? |
| Chlamydiaceae | 2 | 2018 | 5 | 0.88 | Why? |
| Switzerland | 18 | 2021 | 2738 | 0.87 | Why? |
| Mycobacterium kansasii | 1 | 2019 | 14 | 0.79 | Why? |
| Bacterial Typing Techniques | 2 | 2019 | 273 | 0.79 | Why? |
| Coxiella | 1 | 2018 | 6 | 0.78 | Why? |
| Anaplasmataceae | 1 | 2018 | 14 | 0.78 | Why? |
| Gram-Negative Bacterial Infections | 4 | 2018 | 398 | 0.76 | Why? |
| Bacteriological Techniques | 3 | 2019 | 239 | 0.75 | Why? |
| Leukocidins | 1 | 2018 | 47 | 0.75 | Why? |
| Psittacosis | 2 | 2017 | 14 | 0.74 | Why? |
| Microbial Sensitivity Tests | 7 | 2019 | 2886 | 0.74 | Why? |
| Exotoxins | 1 | 2018 | 54 | 0.74 | Why? |
| Chlamydophila psittaci | 2 | 2017 | 17 | 0.74 | Why? |
| Anaplasma | 1 | 2017 | 8 | 0.74 | Why? |
| Microbiological Techniques | 2 | 2019 | 232 | 0.72 | Why? |
| Chlamydophila Infections | 2 | 2017 | 21 | 0.72 | Why? |
| Kingella | 1 | 2017 | 6 | 0.72 | Why? |
| Genetic Speciation | 1 | 2017 | 13 | 0.71 | Why? |
| Thymidylate Synthase | 1 | 2017 | 3 | 0.71 | Why? |
| Neisseriaceae Infections | 1 | 2017 | 21 | 0.71 | Why? |
| Proguanil | 1 | 2017 | 23 | 0.70 | Why? |
| Biological Evolution | 3 | 2018 | 641 | 0.70 | Why? |
| Klebsiella pneumoniae | 3 | 2018 | 658 | 0.70 | Why? |
| Tetrahydrofolate Dehydrogenase | 1 | 2017 | 12 | 0.69 | Why? |
| Folic Acid Antagonists | 1 | 2017 | 40 | 0.68 | Why? |
| Mycobacterium | 1 | 2019 | 143 | 0.67 | Why? |
| Ticks | 1 | 2018 | 107 | 0.67 | Why? |
| Tick-Borne Diseases | 1 | 2018 | 68 | 0.66 | Why? |
| Mentors | 2 | 2017 | 372 | 0.64 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.63 | Why? |
| Horse Diseases | 1 | 2017 | 101 | 0.63 | Why? |
| Streptococcus pyogenes | 1 | 2017 | 118 | 0.62 | Why? |
| Peptidoglycan | 1 | 2015 | 27 | 0.62 | Why? |
| Bird Diseases | 1 | 2017 | 130 | 0.60 | Why? |
| Anti-Bacterial Agents | 9 | 2019 | 10083 | 0.60 | Why? |
| Chlamydophila pneumoniae | 3 | 2018 | 98 | 0.60 | Why? |
| Colistin | 1 | 2018 | 217 | 0.60 | Why? |
| beta-Lactamases | 2 | 2019 | 759 | 0.58 | Why? |
| DNA, Bacterial | 9 | 2019 | 835 | 0.57 | Why? |
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3633 | 0.57 | Why? |
| Staphylococcus aureus | 2 | 2018 | 844 | 0.57 | Why? |
| Bacterial Secretion Systems | 1 | 2013 | 2 | 0.55 | Why? |
| Professional Competence | 1 | 2017 | 246 | 0.52 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.51 | Why? |
| Societies, Scientific | 1 | 2016 | 414 | 0.51 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2013 | 143 | 0.50 | Why? |
| Quality Assurance, Health Care | 1 | 2017 | 596 | 0.48 | Why? |
| Antimicrobial Stewardship | 2 | 2018 | 931 | 0.47 | Why? |
| Education | 1 | 2017 | 434 | 0.46 | Why? |
| Phylogeny | 10 | 2019 | 13341 | 0.45 | Why? |
| Hygiene | 1 | 2019 | 987 | 0.45 | Why? |
| Microbiota | 3 | 2018 | 1240 | 0.44 | Why? |
| Abortion, Spontaneous | 2 | 2020 | 776 | 0.43 | Why? |
| Bacteremia | 2 | 2019 | 1372 | 0.42 | Why? |
| Pneumonia, Bacterial | 3 | 2018 | 843 | 0.41 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2010 | 109 | 0.41 | Why? |
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.40 | Why? |
| Toll-Like Receptor 2 | 1 | 2010 | 198 | 0.39 | Why? |
| Disease Management | 2 | 2017 | 6841 | 0.37 | Why? |
| Alveolar Epithelial Cells | 1 | 2017 | 1445 | 0.37 | Why? |
| Yogurt | 2 | 2017 | 8 | 0.36 | Why? |
| Drug Resistance, Bacterial | 6 | 2018 | 1414 | 0.35 | Why? |
| Diagnostic Tests, Routine | 3 | 2021 | 2643 | 0.34 | Why? |
| Toll-Like Receptor 4 | 1 | 2010 | 390 | 0.33 | Why? |
| Chlamydiaceae Infections | 2 | 2017 | 7 | 0.32 | Why? |
| Molecular Typing | 2 | 2018 | 280 | 0.32 | Why? |
| Milk | 2 | 2017 | 158 | 0.31 | Why? |
| Horses | 2 | 2018 | 474 | 0.31 | Why? |
| Molecular Diagnostic Techniques | 4 | 2020 | 4239 | 0.30 | Why? |
| Animals | 20 | 2018 | 78931 | 0.29 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.27 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.27 | Why? |
| Gram-Negative Bacteria | 2 | 2019 | 473 | 0.27 | Why? |
| Immune Sera | 2 | 2020 | 884 | 0.27 | Why? |
| Molecular Epidemiology | 3 | 2019 | 1638 | 0.27 | Why? |
| RNA, Ribosomal, 16S | 3 | 2017 | 793 | 0.27 | Why? |
| Zoonoses | 2 | 2017 | 3034 | 0.26 | Why? |
| Antigens, Bacterial | 1 | 2006 | 330 | 0.26 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.26 | Why? |
| Quinolones | 2 | 2017 | 167 | 0.24 | Why? |
| Humans | 68 | 2021 | 930598 | 0.23 | Why? |
| Neurovascular Coupling | 1 | 2021 | 22 | 0.23 | Why? |
| Clinical Laboratory Techniques | 3 | 2018 | 23402 | 0.23 | Why? |
| Sequence Analysis, DNA | 4 | 2019 | 2830 | 0.23 | Why? |
| Community-Acquired Infections | 2 | 2014 | 2328 | 0.23 | Why? |
| Gills | 2 | 2018 | 10 | 0.22 | Why? |
| Immunosorbent Techniques | 1 | 2020 | 35 | 0.22 | Why? |
| Macrolides | 2 | 2017 | 369 | 0.21 | Why? |
| Atherosclerosis | 1 | 2008 | 768 | 0.21 | Why? |
| Host-Pathogen Interactions | 7 | 2018 | 11041 | 0.20 | Why? |
| Chorionic Villi | 1 | 2020 | 73 | 0.20 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.20 | Why? |
| Pseudarthrosis | 1 | 2019 | 4 | 0.20 | Why? |
| Clostridium | 1 | 2019 | 33 | 0.20 | Why? |
| Mycological Typing Techniques | 1 | 2019 | 38 | 0.20 | Why? |
| Perciformes | 1 | 2018 | 9 | 0.20 | Why? |
| Gastrointestinal Tract | 2 | 2018 | 1113 | 0.19 | Why? |
| Vancomycin Resistance | 1 | 2019 | 55 | 0.19 | Why? |
| Polymyxins | 1 | 2018 | 8 | 0.19 | Why? |
| Nucleic Acid Hybridization | 1 | 2019 | 140 | 0.19 | Why? |
| Bacteriology | 1 | 2017 | 1 | 0.19 | Why? |
| Snakes | 1 | 2018 | 53 | 0.18 | Why? |
| Lactose | 1 | 2017 | 17 | 0.18 | Why? |
| Genotyping Techniques | 1 | 2021 | 360 | 0.18 | Why? |
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 31 | 0.18 | Why? |
| Staphylococcus | 1 | 2018 | 77 | 0.18 | Why? |
| Sympatry | 1 | 2017 | 2 | 0.18 | Why? |
| Bacteriuria | 1 | 2017 | 31 | 0.18 | Why? |
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 3 | 0.18 | Why? |
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 3 | 0.18 | Why? |
| Enterococcus faecium | 1 | 2019 | 95 | 0.18 | Why? |
| Abortion, Septic | 1 | 2017 | 5 | 0.18 | Why? |
| Bass | 1 | 2017 | 2 | 0.18 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2019 | 104 | 0.18 | Why? |
| Trachoma | 1 | 2018 | 48 | 0.18 | Why? |
| Microbial Interactions | 1 | 2018 | 67 | 0.17 | Why? |
| Trimethoprim | 1 | 2017 | 22 | 0.17 | Why? |
| Pyrimethamine | 1 | 2017 | 18 | 0.17 | Why? |
| Bile Acids and Salts | 1 | 2018 | 91 | 0.17 | Why? |
| Endometritis | 1 | 2017 | 12 | 0.17 | Why? |
| Prokaryotic Cells | 1 | 2016 | 15 | 0.17 | Why? |
| Fish Diseases | 1 | 2017 | 22 | 0.17 | Why? |
| Drug Resistance, Microbial | 2 | 2019 | 419 | 0.17 | Why? |
| Clindamycin | 1 | 2017 | 59 | 0.17 | Why? |
| Virulence Factors | 2 | 2017 | 338 | 0.17 | Why? |
| Amoeba | 1 | 2017 | 22 | 0.17 | Why? |
| Vaginosis, Bacterial | 1 | 2017 | 51 | 0.17 | Why? |
| Pseudomonas | 1 | 2017 | 65 | 0.17 | Why? |
| Mycology | 1 | 2016 | 37 | 0.16 | Why? |
| Leptospirosis | 1 | 2017 | 103 | 0.16 | Why? |
| Nontuberculous Mycobacteria | 1 | 2017 | 114 | 0.16 | Why? |
| Diaminopimelic Acid | 1 | 2015 | 7 | 0.16 | Why? |
| Cytoplasm | 1 | 2017 | 304 | 0.16 | Why? |
| Metagenome | 1 | 2018 | 268 | 0.16 | Why? |
| Phenols | 1 | 2018 | 226 | 0.15 | Why? |
| Q Fever | 1 | 2017 | 130 | 0.15 | Why? |
| New South Wales | 1 | 2017 | 336 | 0.15 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2015 | 60 | 0.15 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.15 | Why? |
| Cell Wall | 1 | 2015 | 62 | 0.15 | Why? |
| Cell Division | 1 | 2015 | 136 | 0.15 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.15 | Why? |
| Real-Time Polymerase Chain Reaction | 4 | 2020 | 11367 | 0.15 | Why? |
| Neisseria gonorrhoeae | 1 | 2017 | 142 | 0.15 | Why? |
| Female Urogenital Diseases | 1 | 2015 | 32 | 0.15 | Why? |
| Inappropriate Prescribing | 1 | 2018 | 284 | 0.15 | Why? |
| Male Urogenital Diseases | 1 | 2015 | 30 | 0.15 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.14 | Why? |
| beta-Lactams | 1 | 2017 | 210 | 0.14 | Why? |
| Spermatozoa | 1 | 2018 | 244 | 0.14 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2019 | 323 | 0.14 | Why? |
| Workflow | 3 | 2021 | 2373 | 0.14 | Why? |
| Pneumonia, Mycoplasma | 1 | 2018 | 292 | 0.14 | Why? |
| Asthma | 1 | 2014 | 4383 | 0.14 | Why? |
| Cattle Diseases | 1 | 2017 | 294 | 0.14 | Why? |
| High-Throughput Screening Assays | 2 | 2021 | 1783 | 0.14 | Why? |
| Birds | 1 | 2017 | 412 | 0.14 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.14 | Why? |
| Sensitivity and Specificity | 8 | 2021 | 22971 | 0.13 | Why? |
| Metagenomics | 2 | 2018 | 823 | 0.13 | Why? |
| Lipoproteins | 1 | 2015 | 240 | 0.13 | Why? |
| Disease Outbreaks | 5 | 2019 | 27595 | 0.13 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.13 | Why? |
| Eye | 1 | 2018 | 374 | 0.13 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 13720 | 0.13 | Why? |
| Antibodies, Bacterial | 2 | 2008 | 510 | 0.13 | Why? |
| Hepatitis E virus | 1 | 2017 | 306 | 0.13 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.13 | Why? |
| Gene Order | 1 | 2013 | 144 | 0.13 | Why? |
| Genotype | 4 | 2019 | 4697 | 0.13 | Why? |
| Life Cycle Stages | 1 | 2013 | 162 | 0.13 | Why? |
| Thiazoles | 1 | 2018 | 496 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.12 | Why? |
| Conserved Sequence | 1 | 2015 | 751 | 0.12 | Why? |
| Hepatitis E | 1 | 2017 | 319 | 0.12 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.12 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.12 | Why? |
| Virology | 1 | 2016 | 489 | 0.12 | Why? |
| Papillomavirus Vaccines | 1 | 2017 | 405 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.12 | Why? |
| DNA Topoisomerase IV | 1 | 2010 | 1 | 0.11 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.11 | Why? |
| Environmental Microbiology | 1 | 2016 | 575 | 0.11 | Why? |
| Actinomycetaceae | 1 | 2010 | 10 | 0.11 | Why? |
| Hospitals, University | 2 | 2021 | 4173 | 0.11 | Why? |
| DNA Gyrase | 1 | 2010 | 30 | 0.11 | Why? |
| Peracetic Acid | 1 | 2011 | 68 | 0.11 | Why? |
| Benzalkonium Compounds | 1 | 2011 | 42 | 0.11 | Why? |
| Female | 24 | 2021 | 380317 | 0.11 | Why? |
| Vero Cells | 2 | 2017 | 14117 | 0.10 | Why? |
| Pregnancy | 6 | 2020 | 23879 | 0.10 | Why? |
| Placenta | 3 | 2020 | 1531 | 0.10 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.10 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.10 | Why? |
| Dermatitis, Atopic | 1 | 2017 | 714 | 0.10 | Why? |
| Brain Diseases | 1 | 2021 | 1463 | 0.10 | Why? |
| Uterine Cervical Neoplasms | 1 | 2017 | 842 | 0.10 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.10 | Why? |
| Fluoroquinolones | 1 | 2010 | 235 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.09 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.09 | Why? |
| Phagocytosis | 1 | 2010 | 409 | 0.09 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.09 | Why? |
| Genomics | 2 | 2017 | 3118 | 0.09 | Why? |
| Postprandial Period | 2 | 2017 | 45 | 0.09 | Why? |
| Biofilms | 1 | 2011 | 304 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.09 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.09 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Transcription, Genetic | 1 | 2013 | 1326 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.08 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.08 | Why? |
| Bacterial Infections | 2 | 2017 | 2229 | 0.08 | Why? |
| Molecular Weight | 1 | 2006 | 249 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.08 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2020 | 5164 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.08 | Why? |
| Cross Infection | 2 | 2019 | 8675 | 0.08 | Why? |
| Pregnancy Complications, Infectious | 3 | 2020 | 11559 | 0.08 | Why? |
| Pseudomonas aeruginosa | 1 | 2011 | 652 | 0.08 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.08 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.07 | Why? |
| Infant | 5 | 2021 | 30274 | 0.07 | Why? |
| Diet | 1 | 2017 | 2052 | 0.07 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Immunoglobulin M | 4 | 2021 | 9091 | 0.07 | Why? |
| Cluster Analysis | 1 | 2013 | 3001 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Serologic Tests | 3 | 2021 | 4359 | 0.07 | Why? |
| Regression Analysis | 1 | 2011 | 2484 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Microscopy, Confocal | 2 | 2018 | 343 | 0.06 | Why? |
| Child | 6 | 2021 | 70012 | 0.06 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.06 | Why? |
| Communication | 1 | 2021 | 5206 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Ciprofloxacin | 2 | 2017 | 130 | 0.06 | Why? |
| Azithromycin | 1 | 2018 | 3943 | 0.06 | Why? |
| Biosensing Techniques | 1 | 2017 | 2116 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.06 | Why? |
| Polymerase Chain Reaction | 3 | 2017 | 6740 | 0.06 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.06 | Why? |
| Mice | 3 | 2018 | 21357 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Gene Expression Profiling | 1 | 2013 | 3788 | 0.06 | Why? |
| Adolescent | 8 | 2020 | 86841 | 0.06 | Why? |
| Double-Blind Method | 3 | 2017 | 5988 | 0.06 | Why? |
| Europe | 1 | 2018 | 12702 | 0.06 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.06 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Male | 15 | 2021 | 367725 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Disinfectants | 1 | 2011 | 1077 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Multivariate Analysis | 1 | 2011 | 5440 | 0.05 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2010 | 2483 | 0.05 | Why? |
| Mice, Inbred BALB C | 1 | 2010 | 5814 | 0.05 | Why? |
| Mice, Inbred C57BL | 1 | 2010 | 5542 | 0.05 | Why? |
| Dictyostelium | 1 | 2018 | 2 | 0.05 | Why? |
| Artifacts | 1 | 2021 | 250 | 0.05 | Why? |
| Gluconeogenesis | 1 | 2018 | 41 | 0.05 | Why? |
| Genetic Drift | 1 | 2018 | 54 | 0.05 | Why? |
| Maternal-Fetal Exchange | 1 | 2020 | 209 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Leukocytes, Mononuclear | 1 | 2008 | 2115 | 0.05 | Why? |
| Burkholderia cepacia | 1 | 2018 | 11 | 0.05 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.05 | Why? |
| Pregnancy Trimester, Second | 1 | 2020 | 314 | 0.05 | Why? |
| Sex Distribution | 2 | 2017 | 2083 | 0.05 | Why? |
| Veillonella | 1 | 2017 | 8 | 0.05 | Why? |
| Ketone Bodies | 1 | 2018 | 53 | 0.05 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.05 | Why? |
| Protein Binding | 1 | 2015 | 11430 | 0.05 | Why? |
| Aborted Fetus | 1 | 2017 | 34 | 0.05 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| beta-Galactosidase | 1 | 2017 | 40 | 0.05 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.05 | Why? |
| Infant, Newborn | 4 | 2021 | 23105 | 0.05 | Why? |
| Mutagenesis, Insertional | 1 | 2018 | 92 | 0.05 | Why? |
| Femur | 1 | 2019 | 100 | 0.05 | Why? |
| Macrophages | 1 | 2010 | 2784 | 0.05 | Why? |
| Burkholderia Infections | 1 | 2018 | 33 | 0.04 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2018 | 102 | 0.04 | Why? |
| Adult | 12 | 2021 | 244371 | 0.04 | Why? |
| Type III Secretion Systems | 1 | 2017 | 10 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Leptospira | 1 | 2017 | 48 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Fibroblast Growth Factors | 1 | 2018 | 119 | 0.04 | Why? |
| Legionella | 1 | 2018 | 91 | 0.04 | Why? |
| Galactose | 1 | 2017 | 201 | 0.04 | Why? |
| Membrane Transport Proteins | 1 | 2018 | 152 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Ampicillin | 1 | 2017 | 73 | 0.04 | Why? |
| Coxiella burnetii | 1 | 2017 | 120 | 0.04 | Why? |
| Urinary Tract Infections | 2 | 2015 | 534 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.04 | Why? |
| Hepatitis Antibodies | 1 | 2017 | 100 | 0.04 | Why? |
| Dietary Fats | 1 | 2017 | 96 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2017 | 177 | 0.04 | Why? |
| Base Composition | 1 | 2017 | 203 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Microscopy, Atomic Force | 1 | 2017 | 118 | 0.04 | Why? |
| Fetus | 1 | 2020 | 484 | 0.04 | Why? |
| Age Distribution | 2 | 2017 | 3567 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Respiratory Syncytial Viruses | 1 | 2020 | 612 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Gene Deletion | 1 | 2018 | 430 | 0.04 | Why? |
| Mycoplasma pneumoniae | 1 | 2018 | 233 | 0.04 | Why? |
| Meals | 1 | 2017 | 205 | 0.04 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.04 | Why? |
| Brachial Plexus Neuritis | 1 | 2017 | 130 | 0.04 | Why? |
| Stillbirth | 1 | 2020 | 544 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Pregnancy Outcome | 2 | 2020 | 3803 | 0.04 | Why? |
| Adiposity | 1 | 2018 | 329 | 0.04 | Why? |
| Interleukin-8 | 1 | 2021 | 964 | 0.04 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 167 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Lung | 2 | 2017 | 31049 | 0.04 | Why? |
| Vagina | 1 | 2017 | 327 | 0.04 | Why? |
| Mass Screening | 1 | 2015 | 8005 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Ceftriaxone | 1 | 2017 | 365 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2017 | 867 | 0.03 | Why? |
| Blood Culture | 1 | 2017 | 308 | 0.03 | Why? |
| Influenza B virus | 1 | 2020 | 815 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2018 | 1027 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.03 | Why? |
| Electroencephalography | 1 | 2021 | 1242 | 0.03 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.03 | Why? |
| Eczema | 1 | 2017 | 227 | 0.03 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
| Papillomaviridae | 1 | 2017 | 404 | 0.03 | Why? |
| Allografts | 1 | 2017 | 761 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Infertility, Male | 1 | 2018 | 322 | 0.03 | Why? |
| Gonorrhea | 1 | 2017 | 315 | 0.03 | Why? |
| Aged | 6 | 2021 | 215776 | 0.03 | Why? |
| Immunoenzyme Techniques | 1 | 2015 | 448 | 0.03 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.03 | Why? |
| Interleukin-6 | 1 | 2010 | 7522 | 0.03 | Why? |
| Tertiary Care Centers | 2 | 2021 | 8248 | 0.03 | Why? |
| Urine | 1 | 2015 | 469 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2019 | 1265 | 0.03 | Why? |
| Methyltransferases | 1 | 2017 | 720 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Actinomycetales Infections | 1 | 2010 | 10 | 0.03 | Why? |
| Intestines | 1 | 2017 | 817 | 0.03 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Nanotechnology | 1 | 2017 | 821 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2010 | 170 | 0.02 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2021 | 2844 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2018 | 2149 | 0.02 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.02 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.02 | Why? |
| Sexual Behavior | 1 | 2015 | 1322 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Feasibility Studies | 1 | 2015 | 3467 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2010 | 3198 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.02 | Why? |
| Feces | 1 | 2017 | 4235 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Amino Acid Sequence | 1 | 2010 | 6049 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2015 | 5002 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| France | 1 | 2010 | 12074 | 0.01 | Why? |
| Prevalence | 1 | 2015 | 25773 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Risk Factors | 1 | 2015 | 71621 | 0.00 | Why? |